Patent · US Active

Method to determine contrast media injection parameters to control signal intensity during magnetic resonance angiography

US9744289B2 · kind B2 · utility

0Cited by
7References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2012
Grant dateAug 29, 2017
Priority date
Expiry dateMar 25, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2005/14553
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Injection systems and related methods including an injection device, an operator interface, and modules to determine operational parameters during an MRA imaging procedure. Such parameters may be used to optimize and/or maximize signal intensity during an MRA imaging procedure. The injection system may include a target in-bloodstream contrast agent concentration determination module that determines a target in-bloodstream contrast agent concentration at least partially based on contrast agent type and MRA imager parameters. The injection system may include a contrast agent injection rate determination module that determines a contrast agent injection rate at least partially based on the target in-bloodstream contrast agent concentration, an initial contrast agent concentration, and a cardiac output rate of a patient to be imaged. The injection system may include a diluent injection rate determination module that determines a diluent injection rate at least partially based on the contrast agent injection rate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.